TrialDiabetes, obesity & metabolism2020

Efficacy and safety of empagliflozin as add-on to insulin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Hirohito Sone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.